Cell And Gene Therapy Analytical Services
Source: AGC Biologics

Cell and gene therapies advancing toward clinical trials require robust analytical testing to ensure product quality and safety. However, these processes present a significant bottleneck for manufacturers at the moment. Utilizing a robust technical panel is essential to maintain a competitive edge and maximize therapeutic efficacy.
Maggie Chen, Senior Director, Manufacturing & MSAT, AGC Biologics, reviews how comprehensive analytical services that cover a wide range of project needs can help keep a project on track.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
AGC Biologics
This website uses cookies to ensure you get the best experience on our website. Learn more